Companies /Healthcare

Gilead Sciences Inc

NASDAQ: GILD Drug Manufacturers - General
$156.04
▼ $1.15 (−0.73%) today
Markets closed · 12:36am ET

GILD Coverage Page 21

10:00am ET
Health and Healthcare

Gilead Moves to Acquire Kite Pharma

Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to make a move to shake this situation, otherwise this could turn into…

Chris Lange
2:44pm ET
Health and Healthcare

Gilead Secures FDA Approval For Chronic Hepatitis C Re-Treatment

Gilead Sciences, Inc. (NASDAQ: GILD) shares basically remained unchanged after the firm announced an approval from the U.S. Food and Drug Administration (FDA). Essentially, the FDA approved Vosevi (sofosbuvir 400 mg/velpatasvir 100…

Chris Lange